Literature DB >> 9652189

Fibroblast models of neurological disorders: fluorescence measurement studies.

G P Connolly1.   

Abstract

Biochemical studies of human fibroblasts from patients with neurological disorders have revealed a wealth of information on how such disorders occur. In this review, Gerald Connolly describes how recently developed fluorescence video imaging techniques have been used to study the physiology of skin fibroblasts isolated from patients with certain neurological disorders, including those produced by Alzheimer's disease, Lesch-Nyhan syndrome, mitochondrial disorders, amyotrophic lateral sclerosis and lysosomal disorders. The results of these studies indicate disruptions in cell homeostasis, particularly specific changes in Ca2+ homeostasis and autofluorescence, which mirror changes thought to occur in the CNS of neurologically impaired patients. More extensive studies of these 'systemic changes' using new fluorescent indicators, combined with advances in imaging techniques, are predicted to increase the potential usefulness of human skin fibroblasts as experimental models and to help diagnose and treat neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652189     DOI: 10.1016/s0165-6147(98)01202-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  19 in total

1.  Identification of the nucleotidase responsible for the AMP hydrolysing hyperactivity associated with neurological and developmental disorders.

Authors:  Rossana Pesi; Marcella Camici; Vanna Micheli; Laura Notarantonio; Gabriella Jacomelli; Maria Grazia Tozzi
Journal:  Neurochem Res       Date:  2007-07-06       Impact factor: 3.996

2.  Occurrence of an anomalous endocytic compartment in fibroblasts from Sandhoff disease patients.

Authors:  Brunella Tancini; Alessandro Magini; Loredana Latterini; Lorena Urbanelli; Virginia Ciccarone; Fausto Elisei; Carla Emiliani
Journal:  Mol Cell Biochem       Date:  2009-10-02       Impact factor: 3.396

3.  CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts.

Authors:  Keiichi Inoue; Luis M A Oliveira; Asa Abeliovich
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

4.  Comparative studies on [Ca2+]i-level of fibroblasts from Alzheimer patients and control individuals.

Authors:  A Palotás; J Kálmán; G Laskay; A Juhász; Z Janka; B Penke
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

Review 5.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

Review 6.  Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.

Authors:  M P Mattson; S L Chan
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 7.  Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells.

Authors:  R Etcheberrigaray; S Bhagavan
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

8.  Comparative analysis of gene-expression patterns in human and African great ape cultured fibroblasts.

Authors:  Mazen W Karaman; Marlys L Houck; Leona G Chemnick; Shailender Nagpal; Daniel Chawannakul; Dominick Sudano; Brian L Pike; Vincent V Ho; Oliver A Ryder; Joseph G Hacia
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

9.  Whole blood samples from Alzheimer patients and control donors demonstrate fluorimetric differences.

Authors:  András Palotás; János Kálmán; Miklós Palotás; Keyvan Matin; Károly Szentpáli; Attila Paszt; Zoltán Janka; Botond Penke
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

10.  Microfluidic platform to evaluate migration of cells from patients with DYT1 dystonia.

Authors:  Flavia C Nery; Nadia A Atai; Cintia C da Hora; Edward Y Kim; Jasmin Hettich; Thorsten R Mempel; Xandra O Breakefield; Daniel Irimia
Journal:  J Neurosci Methods       Date:  2014-05-29       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.